PRG-2311

· Tongji Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRG-2311, covering 2024-07-11 to 2024-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease [EARLY_Phase 1]